Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous G-CSF before embryo transfer in IVF patients with recurrent implantation failure
IRCT20230718058835N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female infertility and Recurrent Implantation Failure (RIF) comparing G-CSF with Placebo (2 arms). Primary endpoint: In vitro fertilization (IVF) results. Started Oct 2023; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
female infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20230718058835N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230718058835N1.